Chronic kidney disease (CKD) is one of the common complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT), which is closely related to acute kidney injury (AKI), transplantation-associated thrombotic microangiopathy (TA-TMA), graft versus host disease (GVHD), BK virus (BKV) infection and other factors. Main clinical manifestations of patients with CKD include membranous nephropathy (MN), minimal change disease (MCD), renal injury related TA-TMA and BKV nephropathy (BKV-N). The treatment and prognosis of CKD patients vary with the clinical manifestations. This article mainly summarizes high-risk factors, clinical characteristics, treatment principles and prognosis of patients with CKD after allo-HSCT, in order to improve the clinicians′ understanding of the disease.
